Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
289
-
Total 13F shares, excl. options
-
33.9M
-
Shares change
-
+699K
-
Total reported value, excl. options
-
$1.74B
-
Value change
-
-$17.8M
-
Put/Call ratio
-
1.33
-
Number of buys
-
141
-
Number of sells
-
-189
-
Price
-
$51.43
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q2 2022
438 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q2 2022.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 289 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9M shares
of 162M outstanding shares and own 20.89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.35M shares), BlackRock Inc. (4.26M shares), STATE STREET CORP (2.97M shares), MORGAN STANLEY (1.29M shares), COATUE MANAGEMENT LLC (1.24M shares), CITIGROUP INC (1.22M shares), GEODE CAPITAL MANAGEMENT, LLC (1.02M shares), MILLENNIUM MANAGEMENT LLC (869K shares), VOLORIDGE INVESTMENT MANAGEMENT, LLC (848K shares), and CITADEL ADVISORS LLC (689K shares).
This table shows the top 289 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.